Scilex (SCLX) Competitors $11.96 +1.24 (+11.57%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$11.92 -0.04 (-0.34%) As of 07/25/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SCLX vs. IMAB, TLSA, DERM, CYBN, DMAC, NVCT, PBYI, ACRS, ENGN, and CCCCShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include I-Mab (IMAB), Tiziana Life Sciences (TLSA), Journey Medical (DERM), Cybin (CYBN), DiaMedica Therapeutics (DMAC), Nuvectis Pharma (NVCT), Puma Biotechnology (PBYI), Aclaris Therapeutics (ACRS), enGene (ENGN), and C4 Therapeutics (CCCC). These companies are all part of the "pharmaceutical products" industry. Scilex vs. Its Competitors I-Mab Tiziana Life Sciences Journey Medical Cybin DiaMedica Therapeutics Nuvectis Pharma Puma Biotechnology Aclaris Therapeutics enGene C4 Therapeutics Scilex (NASDAQ:SCLX) and I-Mab (NASDAQ:IMAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends. Is SCLX or IMAB more profitable? I-Mab has a net margin of 0.00% compared to Scilex's net margin of -146.93%. Scilex's return on equity of 0.00% beat I-Mab's return on equity.Company Net Margins Return on Equity Return on Assets Scilex-146.93% N/A -82.65% I-Mab N/A -19.81%-18.63% Do institutionals & insiders have more ownership in SCLX or IMAB? 69.7% of Scilex shares are held by institutional investors. Comparatively, 38.4% of I-Mab shares are held by institutional investors. 7.9% of Scilex shares are held by insiders. Comparatively, 22.1% of I-Mab shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer SCLX or IMAB? Scilex presently has a consensus price target of $455.00, suggesting a potential upside of 3,704.35%. I-Mab has a consensus price target of $6.00, suggesting a potential upside of 184.36%. Given Scilex's higher probable upside, research analysts plainly believe Scilex is more favorable than I-Mab.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scilex 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50I-Mab 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media favor SCLX or IMAB? In the previous week, I-Mab had 1 more articles in the media than Scilex. MarketBeat recorded 3 mentions for I-Mab and 2 mentions for Scilex. Scilex's average media sentiment score of 0.93 beat I-Mab's score of 0.46 indicating that Scilex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Scilex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive I-Mab 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, SCLX or IMAB? I-Mab has lower revenue, but higher earnings than Scilex. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScilex$56.59M1.47-$72.81M-$29.02-0.41I-MabN/AN/A-$22.23MN/AN/A Which has more risk and volatility, SCLX or IMAB? Scilex has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, I-Mab has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. SummaryI-Mab beats Scilex on 8 of the 13 factors compared between the two stocks. Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLX vs. The Competition Export to ExcelMetricScilexMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.52M$3.06B$5.69B$9.50BDividend YieldN/A2.37%4.58%4.01%P/E Ratio-0.4121.1828.1020.05Price / Sales1.47288.50432.4490.07Price / CashN/A42.7636.2258.56Price / Book-0.438.378.665.87Net Income-$72.81M-$55.19M$3.25B$258.55M7 Day Performance34.99%5.88%4.23%3.74%1 Month Performance125.66%17.33%10.52%11.75%1 Year Performance-79.66%4.42%34.41%18.03% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXScilex2.3844 of 5 stars$11.96+11.6%$455.00+3,704.3%-79.9%$74.52M$56.59M-0.4180News CoverageIMABI-Mab2.8566 of 5 stars$2.14+0.5%$6.00+180.4%+51.8%$174.75M$3.89M0.00380Gap DownTLSATiziana Life Sciences1.2071 of 5 stars$1.48flatN/A+93.1%$172.94MN/A0.008DERMJourney Medical2.334 of 5 stars$7.41+3.6%$9.50+28.2%+42.4%$172.65M$56.13M-19.0090High Trading VolumeCYBNCybin2.7149 of 5 stars$7.47-2.2%$85.00+1,037.9%N/A$171.99MN/A-1.7150DMACDiaMedica Therapeutics1.5004 of 5 stars$4.01+10.5%$8.00+99.5%+36.9%$171.95MN/A-6.2720News CoverageInsider TradeHigh Trading VolumeNVCTNuvectis Pharma2.8678 of 5 stars$8.22+4.3%$17.00+106.8%+17.5%$171.75MN/A-7.278Positive NewsPBYIPuma Biotechnology4.2383 of 5 stars$3.45+1.8%$7.00+102.9%-16.8%$171.22M$230.50M4.48200Upcoming EarningsACRSAclaris Therapeutics2.3809 of 5 stars$1.58+0.6%$8.71+451.5%+25.9%$171.08M$18.72M-1.14100ENGNenGene2.8343 of 5 stars$3.34+0.9%$23.29+597.2%-58.9%$170.67MN/A-2.0231CCCCC4 Therapeutics3.1629 of 5 stars$2.38+6.7%$12.00+404.2%-64.9%$169.00M$35.58M-1.62150Positive NewsUpcoming Earnings Related Companies and Tools Related Companies IMAB Alternatives TLSA Alternatives DERM Alternatives CYBN Alternatives DMAC Alternatives NVCT Alternatives PBYI Alternatives ACRS Alternatives ENGN Alternatives CCCC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCLX) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.